◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Guardian Pharmacy Services, Inc.

CIK: 1802255 SIC: 5912
$1.45B
Revenue
$49.22M
Net Income
20.21%
Gross Margin
5.02%
Op. Margin
$155.29M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 6 of 4 quarterly reports available
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
+ Total Revenue $397.62M $377.43M $344.33M $329.31M $338.57M $314.39M
Revenue Growth % (YoY) 17.4% 20.0% nan% nan% nan% nan%
Cost of Revenue $312.11M $302.71M $276.19M $264.96M $271.46M $253.51M
+ Gross Profit $85.50M $74.72M $68.15M $64.35M $67.10M $60.88M
Gross Margin % 21.5% 19.8% 19.8% 19.5% 19.8% 19.4%
Selling General & Admin $54.74M $58.37M $55.57M $51.34M $50.35M $165.49M
+ Operating Income $30.76M $16.35M $12.58M $13.01M $16.75M $-104.61M
Operating Margin % 7.7% 4.3% 3.7% 3.9% 4.9% -33.3%
Interest Expense $140.00K $510.00K $345.00K $175.00K $270.00K $2.85M
Other Income/Expense $500.00K $437.00K $179.00K $271.00K $-113.00K $-2.00K
Income Before Tax $31.10M $16.63M $12.59M $13.11M $16.22M $-105.64M
Income Tax Expense $9.83M $7.04M $3.76M $3.83M $4.38M $176.00K
+ Net Income $20.92M $9.82M $9.03M $9.45M $11.94M $-121.99M
Net Margin % 5.3% 2.6% 2.6% 2.9% 3.5% -38.8%
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Cash & Cash Equivalents $65.62M $36.49M $18.82M $14.00M $4.66M $37.22M
Accounts Receivable $101.61M $106.19M $94.12M $97.41M $97.15M $90.94M
Inventory $43.36M $47.86M $44.16M $43.43M $40.55M $45.22M
Other Current Assets $11.04M $7.75M $13.36M $11.20M $9.62M $6.88M
Total Current Assets $221.63M $198.28M $170.46M $166.04M $151.99M $180.26M
Property Plant & Equipment $55.52M $56.12M $54.43M $51.47M $49.88M $48.12M
Goodwill $79.74M $79.57M $76.16M $69.30M $69.30M $68.42M
Intangible Assets $18.48M $18.91M $17.59M $14.08M $14.91M $15.15M
Other Non-current Assets $436.00K $387.00K $386.00K $388.00K $383.00K $374.00K
Total Assets $412.66M $390.04M $356.33M $334.00M $320.81M $348.03M
Accounts Payable $116.21M $121.67M $104.99M $101.67M $102.42M $106.87M
Other Current Liabilities $22.30M $17.61M $14.52M $26.48M $20.43M $15.10M
Total Current Liabilities $160.70M $161.95M $143.99M $145.30M $144.12M $158.32M
Long-term Debt - - - - - -
Other Non-current Liabilities $4.04M $5.22M $6.16M $3.69M $3.42M $3.31M
Total Liabilities $194.73M $194.54M $176.66M $170.78M $170.83M $214.13M
Retained Earnings $66.34M $45.42M $35.60M $26.57M $17.12M $5.18M
Total Stockholders Equity $217.92M $195.50M $179.67M $163.22M $149.98M $133.90M
Total Liabilities & Equity $412.66M $390.04M $356.33M $334.00M $320.81M $348.03M
Breakdown Q4 2025
(Dec 31, 2025)
Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Net Income $20.92M $9.82M $9.03M $9.45M $11.94M $-121.99M
Depreciation & Amortization $5.74M $16.59M $10.76M $5.27M $5.15M $14.62M
Stock-based Compensation $1.08M $12.77M $8.41M $3.97M $3.46M $128.03M
Change in Receivables $-3.04M $11.59M $-1.59M $1.01M $8.20M $17.29M
Change in Inventory $-4.79M $5.67M $2.48M $2.88M $-5.08M $6.23M
Change in Payables $-4.75M $21.15M $3.75M $1.87M $-928.00K $14.16M
Operating Cash Flow $34.60M $65.66M $37.49M $17.55M $22.34M $35.62M
Capital Expenditure $495.00K $12.92M $8.92M - $2.25M $12.46M
Investing Cash Flow $-4.71M $-27.52M $-18.55M $-5.54M $-6.62M $-23.78M
Stock Issued - $29.04M $29.04M - - $119.78M
Stock Repurchased - - $29.04M - - $55.18M
Financing Cash Flow $-758.00K $-6.31M $-4.78M $-2.67M $-48.27M $24.63M
Net Change in Cash $29.13M $31.83M $14.16M $9.34M $-32.56M $36.47M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $377.43M - $1.05B -
Cost of Revenue $302.71M - $843.85M -
Gross Profit $74.72M - $207.22M -
Selling General & Admin $58.37M - $165.28M -
Operating Income $16.35M - $41.94M -
Interest Expense $160.00K - $510.00K -
Other Income/Expense $437.00K - $887.00K -
Income Before Tax $16.63M - $42.32M -
Income Tax Expense $7.04M - $14.63M -
Net Income $9.82M $15.85M $28.30M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $36.49M $4.66M
Accounts Receivable $106.19M $97.15M
Inventory $47.86M $40.55M
Other Current Assets $7.75M $9.62M
Total Current Assets $198.28M $151.99M
Property Plant & Equipment $56.12M $49.88M
Goodwill $79.57M $69.30M
Intangible Assets $18.91M $14.91M
Other Non-current Assets $387.00K $383.00K
Total Assets $390.04M $320.81M
Accounts Payable $121.67M $102.42M
Other Current Liabilities $17.61M $20.43M
Total Current Liabilities $161.95M $144.12M
Other Non-current Liabilities $5.22M $3.42M
Total Liabilities $194.54M $170.83M
Retained Earnings $45.42M $17.12M
Total Stockholders Equity $195.50M $149.98M
Total Liabilities & Equity $390.04M $320.81M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $9.82M $15.85M $28.30M -
Depreciation & Amortization - - $16.59M -
Stock-based Compensation - - $12.77M -
Change in Receivables - - $11.59M -
Change in Inventory - - $5.67M -
Change in Payables - - $21.15M -
Operating Cash Flow - - $65.66M -
Capital Expenditure - - $12.92M -
Investing Cash Flow - - $-27.52M -
Stock Issued - - $29.04M -
Financing Cash Flow - - $-6.31M -
Net Change in Cash - - $31.83M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...